ArticleCureus2025
Clinical Profiles and Predictors of Mortality in Intracerebral Hemorrhage: A Prospective Cohort Study From Western India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntracerebral hemorrhage (ICH) is a significant type of stroke associated with high early mortality. While certain risk factors are known, detailed clinical profiles and predictors of death, especially in varied healthcare environments, require further investigation to guide treatment strategies.
objectiveThis study aimed to measure how common modifiable and non-modifiable risk factors are in ICH patients and to determine which clinical, biochemical, and radiological factors predict death using standard severity scales.
methodsAn observational study enrolled 100 consecutive ICH patients with altered sensorium at Sir Takhtasinhji General Hospital, Bhavnagar, India, over a 12-month period. Data included demographics, comorbidities (hypertension, diabetes, smoking, alcohol), clinical features (hemiplegia, speech disorders), admission blood pressure, biochemical markers (hemoglobin (Hb), random blood sugar (RBS)), hematoma characteristics (volume/location via imaging), and severity scores (Glasgow Coma Scale (GCS), ICH, National Institutes of Health Stroke Scale (NIHSS)). Outcomes (survival/mortality) were analyzed using regression to identify predictors (SPSS; p<0.05 significant).
resultsThe study found high rates of modifiable risk factors: smoking (N=56; 56%), alcohol use (N=40; 40%), hypertension (N=42; 42%), and diabetes (N=44; 44%). Clinically, hemiplegia was present in 82% (N=82) of patients, speech disorder in 68% (N=68), and altered sensorium in 56% (N=56). Admission blood pressure was elevated on average (systolic blood pressure (SBP) 148 mmHg; diastolic blood pressure (DBP) 88 mmHg). Basal ganglia hemorrhage was the most common hematoma location (N=43; 43%), followed by lobar (N=25; 25%) and thalamic (N=19; 19%) sites. Patients had severe presentations: average GCS was 8.7, ICH score 2.1, and NIHSS 19.1. Several factors significantly predicted higher mortality: altered sensorium, speech disorders, high blood sugar (hyperglycemia), elevated admission blood pressure, a higher ICH score, intraventricular bleeding, and the need for ventilator support. Overall mortality was 33% (N=33).
conclusionsThis study identifies admission hyperglycemia, hypertension, and neurologic impairment (GCS ≤8) as modifiable predictors of ICH mortality, emphasizing urgent targeting of these factors in low- to middle-income country (LMIC) settings. Novel findings include the dominant role of speech disorders and hyperglycemia, previously underprioritized, in prognostication. Future research must validate rapid intervention protocols for these predictors and explore socioeconomic barriers to care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.